What Does Bicara Therapeutics CEO Sale Signal Investors
When a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
We compare the 2024 outlook for index funds and target date funds to help you choose the right retirement path.
23,982 articlesWhen a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
A surprise performance of Avril Lavigne’s “Sk8er Boi” at a high-profile wedding became more than nostalgia — it highl...
El Paso’s airspace returns to normal as drone disruptions end, paving the way for resumed flights and new budgeting d...
As 2025 unfolds, sight sciences (sght) 2025 becomes a focal point for ophthalmology investors. This guide breaks down...
Rhode Island’s small firms drive growth, jobs, and innovation. This article explains how a high-earner surtax would a...
The House approved a veterans benefits expansion funded by higher VA refinance fees, prompting a national debate over...
Anthropic filed confidentially for an IPO on June 1, 2026, signaling a landmark tech debut. For individual investors,...
A closer look at Janus Henderson's CLO ETFs shows a safety-first anchor in JAAA and a bolder, higher-yield challenger...
You don’t have to run every deal to build real estate wealth. This guide shows how to fire yourself still scale—deleg...
Recalls are part of the auto business, but the year, same ford problem: can still test investors. This article breaks...
How did xplr (xifr) perform in Q1 2026, and what does it mean for 2026 earnings guidance? This article breaks down th...
Worries about the economy are common, especially when loans loom large. This guide breaks down practical steps you ca...